(PJT) PJT Partners - Overview
Stock: Strategic Advisory, Capital Markets, Restructuring, Shareholder Advisory
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.63% |
| Yield on Cost 5y | 1.49% |
| Yield CAGR 5y | -25.23% |
| Payout Consistency | 86.0% |
| Payout Ratio | 22.5% |
| Risk 5d forecast | |
|---|---|
| Volatility | 38.1% |
| Relative Tail Risk | -7.40% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.21 |
| Alpha | -23.22 |
| Character TTM | |
|---|---|
| Beta | 1.000 |
| Beta Downside | 0.905 |
| Drawdowns 3y | |
|---|---|
| Max DD | 29.25% |
| CAGR/Max DD | 1.02 |
Description: PJT PJT Partners January 07, 2026
PJT Partners Inc. (NYSE:PJT) is a boutique investment bank that delivers strategic, shareholder, capital-markets, and restructuring advisory services to corporations, sponsors, institutional investors, and governments worldwide. Its core offerings span M&A (including contested deals and spin-offs), activism defense, joint-venture structuring, debt and equity financing, IPOs, private placements, and geopolitical policy guidance. The firm also advises on liability management, distressed transactions, and provides private-fund fundraising and liquidity solutions for general and limited partners.
Key operating metrics (FY 2023) show total fee revenue of approximately $1.2 billion, with advisory fees representing roughly 70 % of the mix and a net profit margin near 17 %. PJT’s earnings are closely tied to macro drivers such as global M&A volume (which rose ~12 % YoY in 2023) and the level of corporate debt issuance, both of which tend to accelerate in a low-interest-rate environment but can contract sharply if rates rise sharply. The firm’s balance sheet remains strong, with a cash-to-debt ratio of 1.4×, providing flexibility to weather periods of reduced deal flow.
For a deeper quantitative view, you might explore PJT’s metrics on ValueRay to complement this high-level overview.
Piotroski VR‑10 (Strict, 0-10) 8.0
| Net Income: 178.1m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.31 > 0.02 and ΔFCF/TA 2.03 > 1.0 |
| NWC/Revenue: 41.89% < 20% (prev 30.41%; Δ 11.48% < -1%) |
| CFO/TA 0.33 > 3% & CFO 566.3m > Net Income 178.1m |
| Net Debt (12.8m) to EBITDA (409.6m): 0.03 < 3 |
| Current Ratio: 9.87 > 1.5 & < 3 |
| Outstanding Shares: last quarter (43.4m) vs 12m ago -2.69% < -2% |
| Gross Margin: 31.92% > 18% (prev 0.30%; Δ 3161 % > 0.5%) |
| Asset Turnover: 101.0% > 50% (prev 86.21%; Δ 14.80% > 0%) |
| Interest Coverage Ratio: 6.32 > 6 (EBITDA TTM 409.6m / Interest Expense TTM 60.7m) |
Altman Z'' 5.31
| A: 0.40 (Total Current Assets 771.8m - Total Current Liabilities 78.2m) / Total Assets 1.72b |
| B: 0.20 (Retained Earnings 336.9m / Total Assets 1.72b) |
| C: 0.23 (EBIT TTM 383.6m / Avg Total Assets 1.64b) |
| D: 0.43 (Book Value of Equity 340.1m / Total Liabilities 788.7m) |
| Altman-Z'' Score: 5.31 = AAA |
Beneish M -3.42
| DSRI: 0.88 (Receivables 371.3m/343.6m, Revenue 1.66b/1.34b) |
| GMI: 0.95 (GM 31.92% / 30.21%) |
| AQI: 0.70 (AQ_t 0.33 / AQ_t-1 0.47) |
| SGI: 1.23 (Revenue 1.66b / 1.34b) |
| TATA: -0.23 (NI 178.1m - CFO 566.3m) / TA 1.72b) |
| Beneish M-Score: -3.42 (Cap -4..+1) = AA |
What is the price of PJT shares?
Over the past week, the price has changed by -6.09%, over one month by -10.43%, over three months by -3.28% and over the past year by -7.60%.
Is PJT a buy, sell or hold?
- StrongBuy: 0
- Buy: 0
- Hold: 5
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the PJT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 182.4 | 12.2% |
| Analysts Target Price | 182.4 | 12.2% |
| ValueRay Target Price | 196.5 | 20.9% |
PJT Fundamental Data Overview February 04, 2026
P/E Forward = 21.7865
P/S = 4.171
P/B = 18.5461
P/EG = 1.36
Revenue TTM = 1.66b USD
EBIT TTM = 383.6m USD
EBITDA TTM = 409.6m USD
Long Term Debt = 413.2m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 28.9m USD (from shortTermDebt, last fiscal year)
Debt = 413.2m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 12.8m USD (from netDebt column, last quarter)
Enterprise Value = 6.93b USD (6.91b + Debt 413.2m - CCE 400.5m)
Interest Coverage Ratio = 6.32 (Ebit TTM 383.6m / Interest Expense TTM 60.7m)
EV/FCF = 12.90x (Enterprise Value 6.93b / FCF TTM 537.2m)
FCF Yield = 7.75% (FCF TTM 537.2m / Enterprise Value 6.93b)
FCF Margin = 32.44% (FCF TTM 537.2m / Revenue TTM 1.66b)
Net Margin = 10.75% (Net Income TTM 178.1m / Revenue TTM 1.66b)
Gross Margin = 31.92% ((Revenue TTM 1.66b - Cost of Revenue TTM 1.13b) / Revenue TTM)
Gross Margin QoQ = 32.16% (prev 31.96%)
Tobins Q-Ratio = 4.03 (Enterprise Value 6.93b / Total Assets 1.72b)
Interest Expense / Debt = 4.11% (Interest Expense 17.0m / Debt 413.2m)
Taxrate = 17.59% (16.0m / 91.0m)
NOPAT = 316.1m (EBIT 383.6m * (1 - 17.59%))
Current Ratio = 9.87 (Total Current Assets 771.8m / Total Current Liabilities 78.2m)
Debt / Equity = 1.81 (Debt 413.2m / totalStockholderEquity, last quarter 228.6m)
Debt / EBITDA = 0.03 (Net Debt 12.8m / EBITDA 409.6m)
Debt / FCF = 0.02 (Net Debt 12.8m / FCF TTM 537.2m)
Total Stockholder Equity = 183.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 10.86% (Net Income 178.1m / Total Assets 1.72b)
RoE = 97.32% (Net Income TTM 178.1m / Total Stockholder Equity 183.0m)
RoCE = 64.34% (EBIT 383.6m / Capital Employed (Equity 183.0m + L.T.Debt 413.2m))
RoIC = 172.8% (NOPAT 316.1m / Invested Capital 183.0m)
WACC = 9.25% (E(6.91b)/V(7.33b) * Re(9.60%) + D(413.2m)/V(7.33b) * Rd(4.11%) * (1-Tc(0.18)))
Discount Rate = 9.60% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 30.87%
[DCF Debug] Terminal Value 76.60% ; FCFF base≈504.6m ; Y1≈595.6m ; Y5≈916.5m
Fair Price DCF = 512.0 (EV 12.46b - Net Debt 12.8m = Equity 12.45b / Shares 24.3m; r=9.25% [WACC]; 5y FCF grow 19.24% → 2.90% )
EPS Correlation: 42.79 | EPS CAGR: 5.38% | SUE: 1.62 | # QB: 1
Revenue Correlation: 74.32 | Revenue CAGR: 9.95% | SUE: 1.42 | # QB: 1
EPS next Quarter (2026-03-31): EPS=1.35 | Chg30d=+0.014 | Revisions Net=+2 | Analysts=6
EPS next Year (2026-12-31): EPS=7.62 | Chg30d=-0.091 | Revisions Net=+0 | Growth EPS=+9.8% | Growth Revenue=+10.9%